Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

Summary Background Mortality within the first 6 months after initiating antiretroviral therapy is common in resource-limited settings and is often due to tuberculosis in patients with advanced HIV disease. Isoniazid preventive therapy is recommended in HIV-positive adults, but subclinical tuberculos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2016-03, Vol.387 (10024), p.1198-1209
Hauptverfasser: Hosseinipour, Mina C, Prof, Bisson, Gregory P, MD, Miyahara, Sachiko, PhD, Sun, Xin, MS, Moses, Agnes, MMED, Riviere, Cynthia, MD, Kirui, Fredrick K, MMED, Badal-Faesen, Sharlaa, MBBCh, Lagat, David, MBChB, Nyirenda, Mulinda, MMED, Naidoo, Kogieleum, MBChB, Hakim, James, Prof, Mugyenyi, Peter, Prof, Henostroza, German, MD, Leger, Paul D, MD, Lama, Javier R, MD, Mohapi, Lerato, MBBCh, Alave, Jorge, MD, Mave, Vidya, MD, Veloso, Valdilea G, MD, Pillay, Sandy, MBChB, Kumarasamy, Nagalingeswaran, PhD, Bao, Jing, MD, Hogg, Evelyn, BA, Jones, Lynne, MT ASCP, Zolopa, Andrew, Prof, Kumwenda, Johnstone, Prof, Gupta, Amita, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!